| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-06 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-06 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-06 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-06 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-06 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.23 | 8e-06 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |